HASLER HANS PETER
SEC insider (Form 3/4/5 filer). CIK 0001226286. Director at Gain Therapeutics, Inc. (GANX) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in BETHESDA, MD.
Companies HASLER HANS PETER has filed insider reports for
- Gain Therapeutics, Inc. (GANX): Director
- Minerva Neurosciences, Inc. (NERV): Director
HASLER HANS PETER
CIK: 0001226286
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 15, 2026GANX
Gain Therapeutics, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Jun 3, 2026NERV
Minerva Neurosciences, Inc.
AwardDirectStock Option (right to buy)
50K shares- - Dec 22, 2025NERV
Minerva Neurosciences, Inc.
AwardDirectStock Option (right to buy)
50K shares- - Jun 24, 2025GANX
Gain Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15K shares- - Dec 5, 2024NERV
Minerva Neurosciences, Inc.
AwardDirectStock Option (right to buy)
12.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  GANX Gain Therapeutics, Inc. | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
| Jun 3, 2026 |  NERV Minerva Neurosciences, Inc. | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
| Dec 22, 2025 | NERV Minerva Neurosciences, Inc. | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
| Jun 24, 2025 | GANX Gain Therapeutics, Inc. | Award Stock Option (right to buy) | 15,000 | - | - | Direct |
| Dec 5, 2024 | NERV Minerva Neurosciences, Inc. | Award Stock Option (right to buy) | 12,500 | - | - | Direct |
1-5 of 5 transactions